Philip L. Hooper
- Molecular Biology
- Physiology top 5%
- Ophthalmology top 1%
- Cell Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Paul L. HooperLászló Vı́ghHenry J. KaplanMichael TytellNarsing A. RaoRonald E. SmithTom SheidowIbolya Horváth
- Topics
- Retinal Diseases and Treatments (13 papers)Heat shock proteins research (12 papers)Glaucoma and retinal disorders (9 papers)
- Cited by
- OphthalmologyRehabilitationAging
- Partner nations
- United StatesCanadaHungary
In The Last Decade
Philip L. Hooper
63 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 144
- Molecular Biology 646
- Physiology 587
- Ophthalmology 500
- Cell Biology 247
- Radiology, Nuclear Medicine and Imaging 229
Countries citing papers authored by Philip L. Hooper
This map shows the geographic impact of Philip L. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Hooper more than expected).
Fields of papers citing papers by Philip L. Hooper
This network shows the impact of papers produced by Philip L. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Hooper. The network helps show where Philip L. Hooper may publish in the future.
Co-authorship network of co-authors of Philip L. Hooper
This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Hooper. A scholar is included among the top collaborators of Philip L. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Hooper. Philip L. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 49 | |
| 3 | 26 | |
| 4 | 13 | |
| 5 | 2 | |
| 6 | 31 | |
| 7 | 18 | |
| 8 | 7 | |
| 9 | 33 | |
| 10 | 4 | |
| 11 | 81 | |
| 12 | 8 | |
| 13 | 20 | |
| 14 | Combination Therapy in Neovascular Age-Related Macular Degeneration (amd): A Three-Armed, Randomized, Prospective Clinical Trial of Low Fluence Photodynamic Therapy (rpdt) With Adjunctive Avastin and Triamcinolone Acetonide (Kenalog)(Triple Therapy) versus Rpdt With Adjunctive Avastin (Double Therapy) versus Monotherapy With Avastin | 1 |
| 15 | 425 | |
| 16 | Visudyne Anti-VEGF Combination Therapy (VACT): A Multicentred, Retrospective Clinical Practice Review of Combination Therapy in AMD | 1 |
| 17 | 35 | |
| 18 | 3 | |
| 19 | 14 | |
| 20 | 5 |
About Philip L. Hooper
Philip L. Hooper is a scholar working on Ophthalmology, Aging and Physiology, having authored 65 papers that have together received 2.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (13 papers), Heat shock proteins research (12 papers) and Glaucoma and retinal disorders (9 papers). The work is most often cited by research in Ophthalmology (500 citations), Rehabilitation (196 citations) and Aging (48 citations). Philip L. Hooper has collaborated with scholars based in United States, Canada and Hungary. Frequent co-authors include Paul L. Hooper, László Vı́gh, Henry J. Kaplan, Michael Tytell, Narsing A. Rao, Ronald E. Smith, Tom Sheidow, Ibolya Horváth, Anna G. Holmes and Graeme I. Lancaster. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.